Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John Postiglione"'
Autor:
Arti Hurria, John Postiglione, Kayo Togawa, Kurt Hansen, Richard Stone, Hyman B. Muss, Andrew S. Artz, Constance Cirrincione, Vani Katheria, Douglas Weckstein, Alice B. Kornblith, Ilene Galinsky, William P. Tew, William T. Barry, Linda Schmieder, Rafat Ansari, Jeffrey J. Kirshner, Harvey J. Cohen
Publikováno v:
Journal of Clinical Oncology. 29:1290-1296
Purpose Factors captured in a geriatric assessment can predict morbidity and mortality in older adults, but are not routinely measured in cancer clinical trials. This study evaluated the implementation of a geriatric assessment tool in the cooperativ
Autor:
Steve Devine, John Postiglione, S. Giralt, David D. Hurd, Thomas G. Martin, Kouros Owzar, Jan S. Moreb, Hani Hassoun, Vera Hars, Craig C. Hofmeister, KC Anderson, Edward A. Stadtmauer, Daniel J. Weisdorf, P. G. Richardson, Sarah A. Holstein, Nancy Callander, P.L. McCarthy, Chen Jiang, Ravi Vij, Marcelo C. Pasquini, Thomas C. Shea
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e61-e62
Autor:
Sarah A. Holstein, Edward A. Stadtmauer, John Postiglione, Vera Hars, Ravi Vij, Jan S. Moreb, Thomas C. Shea, Hani Hassoun, Philip L. McCarthy, Steven M. Devine, Paul G. Richardson, Kenneth C. Anderson, Chen Jiang, Sergio Giralt, Craig C. Hofmeister, David D. Hurd, Thomas G. Martin, Natalie S. Callander, Kouros Owzar, Daniel J. Weisdorf
Publikováno v:
Journal of Clinical Oncology. 33:8523-8523
8523 Background: CALGB 100104 studied Len vs. PBO maintenance following ASCT for newly diagnosed MM patients (pts), demonstrating improved time to progression (TTP), overall survival (OS) and increase in second primary malignancies (SPM) for Len at 3
Autor:
Thomas C. Shea, Muzaffar H. Qazilbash, Don A. Gabriel, Koen van Besien, Philip L. McCarthy, Ravi Vij, Charles A. Linker, Mary M. Horowitz, Edward A. Stadtmauer, Michael Kelly, David D. Hurd, Asad Bashey, Heather Landau, John Postiglione, Steven M. Devine, Paul G. Richardson, Michele Sexton, Jan S. Moreb, Kenneth C. Anderson, Cara A. Rosenbaum, Luis Isola, Natalie S. Callander, Craig C. Hofmeister, Hari Parameswaran, Marcelo C. Pasquini, Kouros Owzar, Chen Jiang, Sergio Giralt, Susan Barry, Vera Hars, Thomas Martin, Denise Levitan, Linda Bressler, Richard T. Maziarz, Daniel J. Weisdorf, Elizabeth Bennett, Hani Hassoun, Brian McClune, Teresa C. Gentile
Publikováno v:
Blood. 116:37-37
Abstract 37 The primary objective of CALGB 100104 was to determine if maintenance lenalidomide would prolong time to progression (TTP) after single AHSCT for multiple myeloma. Eligibility included: Stage I-III multiple myeloma, ≤ 1 year from diagno
Autor:
Paul G. Richardson, Michael Kelly, Hani Hassoun, Vera Hars, Edward A. Stadtmauer, Marcelo C. Pasquini, Kenneth C. Anderson, Craig C. Hofmeister, Charles A. Linker, Philip L. McCarthy, Sergio Giralt, John Postiglione, David D. Hurd, Daniel J. Weisdorf, Susan Sutherland, Kouros Owzar
Publikováno v:
Blood. 114:3416-3416
Abstract 3416 Poster Board III-304 Relapse and/or progression of disease are the primary causes of treatment failure after autologous hematopoietic stem cell transplant (ASCT) for multiple myeloma (MM). The primary objective of CALGB 100104 was to in
Autor:
Chen Jiang, Sergio Giralt, Thomas C. Shea, Philip L. McCarthy, Brian McClune, Michael Kelly, Heather Landau, John Postiglione, Thomas G. Martin, Kouros Owzar, Don A. Gabriel, David D. Hurd, Robert L. Schlossman, Teresa Gentile, Natalie S. Callander, Paul G. Richardson, Parameswaran Hari, Cara A. Rosenbaum, Asad Bashey, Charles A. Linker, Ravi Vij, Vera Hars, Denise Levitan, Muzaffar H. Qazilbash, Jan S. Moreb, Mary M. Horowitz, Susan Barry, Michele Seiler, Daniel J. Weisdorf, Kenneth C. Anderson, Craig C. Hofmeister, Elizabeth Bennett, Steven M. Devine, Koen van Besien, Edward A. Stadtmauer, Marcelo C. Pasquini, Luis Isola, Richard T. Maziarz, Hani Hassoun, Linda Bressler
Publikováno v:
ResearcherID
Background Data are lacking on whether lenalidomide maintenance therapy prolongs the time to disease progression after autologous hematopoietic stem-cell transplantation in patients with multiple myeloma. Methods Between April 2005 and July 2009, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7cf44c3e23129a565335ea8fb85604
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000303817000006&KeyUID=WOS:000303817000006
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000303817000006&KeyUID=WOS:000303817000006